Use of Gabapentinoid Medications among US Adults with Cancer, 2005-2015

  Abstract: BACKGROUND:  Gabapentinoid use for long-term cancer pain control may be problematic, given unclear mechanisms of action and increased concerns for physical dependence. The purpose of this report is ...
Continue reading

Don't Be the Don Quixote of Pain Management

AAPM Member and MedPage Today Pain Points blog contributor Heath McAnally, MD , discusses that the overzealous attention to gabapentinoids and its potential for non-indicated prescription, misuse, abuse and adverse effec...
Continue reading
Topics:

Associations Between Gabapentinoids and Suicidal Behavior, Unintentional Overdoses, Injuries, Road Traffic Incidents, and Violent Crime: Population Based Cohort Study in Sweden

Abstract: OBJECTIVE: To examine associations between gabapentinoids and adverse outcomes related to coordination disturbances (head or body injuries, or both and road traffic incidents or offences), mental health (suicid...
Continue reading

A Clinical Overview of Off-label Use of Gabapentinoid Drugs

The gabapentinoid drugs gabapentin and pregabalin were originally developed as antiseizure drugs but now are prescribed mainly for treatment of pain. For gabapentin, the only pain-related indication approved by the US Food and Drug Administration (FDA) is postherpetic neuralgia. For pregabalin, FDA-approved indications related to pain are limited to postherpetic neuralgia, neuropathic pain associated with diabetic neuropathy or spinal cord injury, and fibromyalgia.

Continue reading

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More